Marker Therapeutics to Present at Two Upcoming Investor Conferences
- Tuesday, February 18, 2020, 7:03
- Finance
- Add a comment
HOUSTON, Feb. 18, 2020 /PRNewswire/ — Marker Therapeutics, Inc. (NASDAQ:MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, today…
About the Author
adminasapcorp has written 41558 stories on this site.